It’s birthday celebrations all round. We are celebrating the 20th anniversary
of the General Practice Airways Group (GPIAG). Founded in 1987 as a small
respiratory special-interest group of six general practitioners, the GPIAG
has developed and grown into the largest primary care specialist society in
the UK. It is also coming up to the first birthday of the journal – and we are
hoping that we are giving you a useful ‘goody bag’ of ‘party gifts’ to take
back to your practice after reading this issue.
Editorial
Scoring Top Marks for Asthma QOF Indicators
Asthma is a chronic disease that has, for a long time, been the domain of primary care nurses, and many have qualifications enabling them to run nurse-led asthma clinics. It is, therefore, essential to fully understand the Quality and Outcomes Framework (QOF) and to be able to maximise the points available to the practice, at the same time as providing a comprehensive service to patients. In this article, we review the QOF indicators for asthma, strategies for optimising record keeping and performing asthma reviews.
Why Optimise Inhaler Technique in Asthma and COPD?
Asthma UK estimates that 2.1 million patients in the UK are suffering unnecessarily because
they do not use their asthma treatment effectively. This article looks at how inhaled
therapies are deposited in the lungs, and at the basic differences between inhalers – with
a focus on optimising inhaler technique.
What are my responsibilities as a practice nurse?
The role of nurses working in the National Health Service has undergone major development
in recent years with new roles and expansion of skills into new areas which has included
respiratory care. However, as always, an increased role demands increased responsibility
and this article examines the key legislation affecting practice nurses, and how they can
reduce the risk of medico-legal action.
Selecting the correct over-the-counter medicines for hayfever
Hayfever, or seasonal allergic rhinitis, is a condition that patients often present with to their
pharmacist. However, unlike most minor ailments, hayfever is a persistent and recurrent
condition which can have a significant negative impact on quality of life.1 As such, the
correct diagnosis and product selection is essential. The variety of preparations available for the
treatment of hayfever, both over-the-counter (OTC) and on prescription, was discussed in detail in
an earlier edition of BJPCN.2 This article will focus on the options available to community
pharmacists for OTC treatment of hayfever.
How to write a business case
Skills in developing a business case may at first seem to be something far removed from
what a nurse would need. After all we are clinicians, we do the clinical things and
managers do things like business cases. How wrong could you be? This article shows
just how important business planning can be to both nurses and our patients.
Editorial
Welcome to the first edition of 2008 and my first as Editor in Chief. I want to
thank Jan Procter-King, my predecessor, who has performed an outstanding
role and left the journal in a robust position. I would also like to thank the
members of the Editorial Board – in particular those who have left us or
joined since the last edition. Education for Health (formerly the National
Respiratory Training Centre) has a long reputation in respiratory disease and
we are delighted to be bringing this expertise to the BJPCN Editorial Board.
Reducing Hayfever Havoc: Keeping Symptoms at Bay
Hayfever affects around one in ten adults, and an even higher proportion of children and teenagers. Chronic symptoms may lead to poor concentration, impaired learning ability and school absenteeism in children, amongst other problems. In the run-up to the hayfever season, therefore, it is important to identify teenagers or young adults with persistent or severe hayfever symptoms and to treat their symptoms aggressively to prevent poor performance at school and in examinations. Given that approximately 80% of patients with asthma also have rhinitis, asking your asthma patients about their possible hayfever symptoms is a good starting point.
The effects of the weather on COPD
Those of us working with patients suffering from COPD know anecdotally that cold
weather directly impacts exacerbation rates and hospital admissions in the same way
as thunderstorms affect those with asthma (see BJPCN Vol 1, Issue 2, March 2007).
This article explores the links between COPD and weather patterns. You may not want
to be thinking about the winter but action now should give time to put preventive systems in
place to help at-risk patients before the cold weather appears again.
Useful techniques to manage breathlessness
Although breathlessness is a complex symptom, appropriate management in primary
care can be very rewarding, and does not have to rely on complex, hi-tech
interventions. This article discusses the rationale behind the practical interventions
that practitioners in primary care can consider.
Scoring top marks for smoking cessation
This year, as 1 July and ‘no smoking in public places’ approaches in England, many more
patients will want help to stop smoking. Practices in Scotland and Wales are already
facing this challenge. How do we optimise the smoking cessation advice we offer at the
same time as juggling the many other responsibilities we have? In this article, we look at
how to score top marks for Quality and Outcomes Framework (QOF) indicators on smoking
cessation – recording information and offering advice that will help patients to quit as well as
gaining extra payments for our practices.
How to Treat Winter Coughs and Colds
The number of respiratory consultations in primary care increases in the winter months.
We see more patients with acute exacerbations of their underlying respiratory condition,
such as asthma or chronic obstructive pulmonary disease (COPD) caused by the cold
weather and the increased number of viruses and airborne infections that occur at this
time of year. So what advice should we give to patients with cold and flu-type symptoms during
the winter? And is the approach we take with respiratory patients in any way different from the
approach taken with otherwise healthy individuals?